Xencor presents initial plamotamab data in rheumatoid arthritis at ACR Convergence 2026, updates XmAb657 study
XNCR•Xencor presented initial plamotamab data in rheumatoid arthritis at ACR Convergence 2026 and updated progress in the first-in-human study of XmAb657.
1. Study updates
Xencor presented initial plamotamab data in rheumatoid arthritis at ACR Convergence 2026 and updated progress in the first-in-human study of XmAb657.
